Sen. Menendez Highlights Factors that Contribute to Prescription Drug Shortages
December 05, 2023
December 05, 2023
WASHINGTON, Dec. 5 -- Sen. Robert Menendez, D-New Jersey, issued the following news release:
WASHINGTON, D.C. - U.S. Senator Bob Menendez (D-N.J.), a senior member of the Senate Finance Committee, questioned witnesses during a hearing entitled "Drug Shortages: Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective." The Senator highlighted how the generic drug market's competition, based primarily on price, drives prescription . . .
WASHINGTON, D.C. - U.S. Senator Bob Menendez (D-N.J.), a senior member of the Senate Finance Committee, questioned witnesses during a hearing entitled "Drug Shortages: Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective." The Senator highlighted how the generic drug market's competition, based primarily on price, drives prescription . . .